Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients

Viral Immunology

Volumn 22, Issue 1, 2009, Pages 39-47

  Roe, Barbara ^a   Coughlan, Suzie ^a   Dean, Jonathan ^a   Lambert, John S ^c   Keating, Shay ^d   Norris, Suzanne ^b   Bergin, Colm ^b   Hall, William W ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d Drug Treatment Centre Board   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR3;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL MUTANT; CELL TYPE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EFFECTOR CELL; FEMALE; FUNCTIONAL STATUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LIVER DISEASE; LYMPHOCYTE COUNT; MALE; MEMORY T LYMPHOCYTE; MIXED INFECTION; MORPHOLOGICAL TRAIT; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 60149095138     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0074     Document Type: Article

References (45)

1. Accapezzato D, Francavilla V, Paroli M, et al.: Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004;113:963-972.
2. Al-Harthi L, Voris J, Du W, et al.: Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells. J Infect Dis 2006;193:1202-1210.
3. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
4. Andersson J, Boasso A, Nilsson J, et al.: The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005;174:3143-3147.
5. Apolinario A, Majano PL, Alvarez-Perez E, Saez A, Lozano C, Vargas J, and Garcia-Monzon C: Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 2002;97:2861-2870.
6. Autran B, Carcelain G, Li TS, et al.: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
7. Boettler T, Spangenberg HC, Neumann-Haefelin C, et al.: T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005;79:7860-7867.
8. Brainard DM, Tager AM, Misdraji J, et al.: Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction. J Virol 2007;81:8439-8450.
9. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, and Nelson DR: An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-1071.
10. Capa L, Soriano V, Garcia-Samaniego J, et al.: Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus. J Med Virol 2007;79:503-510.
11. Chan SW, McOmish F, Holmes EC, et al.: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992;73(Pt 5):1131-1141.
12. Cyster JG: Chemorepulsion and thymocyte emigration. J Clin Invest 2002;109:1011-1012.
13. Diepolder HM, Zachoval R, Hoffmann RM, et al.: Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-1007.
14. Dutoit V, Ciuffreda D, Comte D, Gonvers JJ, and Pantaleo G: Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. Eur J Immunol 2005;35:3493-3504.
15. Eggena MP, Barugahare B, Jones N, et al.: Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005;174:4407-4414.
16. Epple HJ, Loddenkemper C, Kunkel D, et al.: Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006;108:3072-3078.
17. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
18. Forster R, Davalos-Misslitz AC, and Rot A: CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008;8:362-371.
19. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, and Lipp M: CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33.
20. Gasper-Smith N, Marriott I, and Bost KL: Murine gamma-herpesvirus 68 limits naturally occurring CD4+CD25+ T regulatory cell activity following infection. J Immunol 2006;177:4670-4678.
21. Graham CS, Wells A, Liu T, et al.: Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS 2005;19:767-773.
22. Grakoui A, Shoukry NH, Woollard DJ, et al.: HCV persistence and immune evasion in the absence of memory T cell help. Science 2003;302:659-662.
23. Ishak K, Baptista A, Bianchi L, et al.: Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
24. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, and Butcher EC: Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001;108:1331-1339.
25. Lechner F, Wong DK, Dunbar PR, et al.: Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000;191:1499-1512.
26. Lee SK, Xu Z, Lieberman J, and Shankar P: The functional CD8 T cell response to HIV becomes type-specific in progressive disease. J Clin Invest 2002;110:1339-1347.
27. Manigold T, Shin EC, Mizukoshi E, et al.: Foxp3+CD4+-CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 2006;107:4424-4432.
28. Michie CA, McLean A, Alcock C, and Beverley PC: Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992;360:264-265.
29. Nisii C, Tempestilli M, Agrati C, et al.: Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection. J Hepatol 2006;44:475-483.
30. Nunez M, Soriano V, Lopez M, Ballesteros C, Cascajero A, Gonzalez-Lahoz J, and Benito JM: Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients. Clin Infect Dis 2006;43:1209-1212.
31. Papagno L, Spina CA, Marchant A, et al.: Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004;2:E20.
32. Poznansky MC, Olszak IT, Evans RH, et al.: Thymocyte emigration is mediated by active movement away from stroma-derived factors. J Clin Invest 2002;109:1101-1110.
33. Roe B, Coughlan S, Hassan J, et al.: Elevated serum levels of interferon-gamma-inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis 2007;196:1053-1057.
34. Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, Klenerman P, and Alexander GJ: Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 2005;79:7852-7859.
35. Sallusto F, Lenig D, Forster R, Lipp M, and Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712.
36. Sallusto F, Lenig D, Mackay CR, and Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-883.
37. Santin M, Mestre M, Shaw E, et al.: Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease. Eur J Clin Microbiol Infect Dis 2008;27:65-73.
38. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, and Adams DH: Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999;163:6236-6243.
39. Shoukry NH, Grakoui A, Houghton M, Chien DY, Ghrayeb J, Reimann KA, and Walker CM: Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003;197:1645-1655.
40. Takahashi T, Kuniyasu Y, Toda M, et al.: Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980.
41. Thornton AM, and Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
42. Velilla PA, Shata MT, Lages CS, Ying J, Fichtenbaum CJ, and Chougnet C: Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients. AIDS Res Hum Retroviruses 2008;24:52-61.
43. Ward SM, Fox BC, Brown PJ, et al.: Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 2007;47:316-324.
44. Wedemeyer H, He XS, Nascimbeni M, et al.: Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002;169:3447-3458.
45. Yamano Y, Takenouchi N, Li HC, Tomaru U, Yao K, Grant CW, Maric DA, and Jacobson S: Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 2005;115:1361-1368.